advertisement

Oculus

11.14 Investigational drugs; pharmacological experiments (45)

Showing records 1 to 25

Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments

Search within classification 11.14 Investigational drugs; pharmacological experiments
81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Angel Aillegas N
Pharmacological Reports 2019; 71: 794-797
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Aihara M
Journal of Glaucoma 2019; 28: 375-385
80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Fan KR
Acta Ophthalmologica 2019; 97: e827-e832
80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Ekicier Acar S
European Journal of Ophthalmology 2019; 0: 1120672119833271
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80720 Causative glaucoma treatment: promising targets and delivery systems
Mietzner R
Drug Discovery Today 2019; 24: 1606-1613
81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Coman IC
Romanian journal of ophthalmology 2019; 63: 135-141
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Sarıcaoğlu MS
European Journal of Ophthalmology 2019; 0: 1120672119833271
81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Al Hammoud M
Romanian journal of ophthalmology 2019; 63: 135-141
81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Tártara LI
Pharmacological Reports 2019; 71: 794-797
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Lu F
Journal of Glaucoma 2019; 28: 375-385
80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Baskaran M
Acta Ophthalmologica 2019; 97: e827-e832
80720 Causative glaucoma treatment: promising targets and delivery systems
Breunig M
Drug Discovery Today 2019; 24: 1606-1613
80599 Neuroprotective effects of topical coenzyme Q10 + vitamin E in mechanic optic nerve injury model
Çolak A
European Journal of Ophthalmology 2019; 0: 1120672119833271
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
81435 The effects of prostaglandins and endocannabinoids on iris arterial vascularization in Wistar rats - Experimental analysis
Tudosescu R
Romanian journal of ophthalmology 2019; 63: 135-141
80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Nongpiur ME
Acta Ophthalmologica 2019; 97: e827-e832
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Kawata H
Journal of Glaucoma 2019; 28: 375-385
81455 Antioxidant status in rabbit aqueous humor after instillation of ascorbyl laurate-based nanostructures
Caballero G
Pharmacological Reports 2019; 71: 794-797
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80575 Phase 2, Randomized, Dose-finding Studies of Omidenepag Isopropyl, a Selective EP2 Agonist, in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Iwata A
Journal of Glaucoma 2019; 28: 375-385
80737 Investigating the neuroprotective effect of Copolymer-1 in acute primary angle closure - Interim report of a randomized placebo-controlled double-masked clinical trial
Htoon HM
Acta Ophthalmologica 2019; 97: e827-e832
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277

Issue 20-3

Select Issue


advertisement

Oculus